The 'Magnificent 7' Are Down 22%—And This $22B Hedge Fund Says These 40 Stocks Are the Real Growth Story
Coatue's latest data reveals the 'Magnificent 7' may be losing their grip—and savvy investors are already positioning for the next wave
The tech investing playbook that made fortunes over the past five years might be getting rewritten in real-time. New data from hedge fund giant Coatue Management reveals a striking shift in the technology landscape that could reshape portfolios—and create opportunities for investors willing to look beyond the usual suspects.
For years, the 'Magnificent 7' tech stocks—Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Alphabet Inc (NASDAQ:GOOG, GOOGL)), Amazon (NASDAQ:AMZN), Tesla (NASDAQ:TSLA), Meta (NASDAQ:META), and Nvidia Corporation(NASDAQ:NVDA)—dominated both headlines and returns. But Coatue's analysis shows cracks forming in this seemingly invincible group.
Don't Miss:
— no wallets, just price speculation and free paper trading to practice different strategies.
Grow your IRA or 401(k) with Crypto – .
The numbers tell the story:
In 2025 year-to-date, four of the seven titans are in negative territory
Apple down 22%, Tesla down 19%, Alphabet down 8%, Amazon down 3%
Only Meta (+17%), Microsoft (+13%), and Nvidia (+6%) remain positive
This marks a dramatic reversal from their collective 1,448% Nvidia surge and triple-digit gains across the board over the past five years
Perhaps more telling is Coatue's research on market leadership turnover. Their data shows that roughly one-fourth to one-third of the top 25 companies by market cap change every five years—but 2025's 16% turnover rate is the lowest since 1995.
What this means for investors: The current leaders may be more entrenched than in previous cycles, but when change comes, it could be swift and dramatic. The AI wave that began in 2022 is already showing signs of creating this next disruption.
Trending: New to crypto? on Coinbase.
Coatue's 'Fantastic 40' projection for 2030 offers a roadmap for where institutional money might be heading. The hedge fund, known for early bets on companies like Uber (NYSE:UBER) and TikTok parent ByteDance, sees massive shifts coming:
The New Giants (Projected 2030 Market Caps):
Microsoft maintaining the No. 1 spot at $5.7 trillion
Nvidia holding strong at No. 2. with $5.6 trillion
Bitcoin/crypto infrastructure plays gaining ground
Enterprise software companies like Palantir (NASDAQ:PLTR) and ServiceNow (NYSE:NOW) breaking into the top 20
The Surprise Inclusions:
SpaceX projected at $871 billion (No. 12)
Several private companies Coatue expects to go public
Emerging fintech and cybersecurity players
Despite the long-term optimism, Coatue's data reveals a concerning pattern: AI-related market scares are becoming more frequent and severe. Three major selloffs in less than a year—including the recent Microsoft capex warning that drove the Nasdaq down 14%—suggest the AI investment thesis remains fragile.
The takeaway: While AI represents the next major tech wave, the path won't be smooth. Investors need to prepare for continued volatility as the market figures out which companies can actually monetize artificial intelligence.1. Diversify Beyond the Mag 7 The concentration risk in big tech is real. Consider spreading exposure across Coatue's broader 'Fantastic 40' list, particularly in areas like cybersecurity (CrowdStrike Holdings (NASDAQ: CRWD)), enterprise software (Palantir), and emerging payment platforms.
2. Prepare for AI Whiplash Keep cash reserves ready for AI-related dips. Coatue's data suggests these selloffs, while painful, create buying opportunities for long-term investors.
3. Watch the Private-to-Public Pipeline Companies like SpaceX, Stripe, and other Coatue holdings may offer the next generation of public market opportunities. Track their funding rounds as potential pre-IPO indicators.
The tech landscape is shifting from a handful of dominant players to a more diverse ecosystem. While the Magnificent 7 aren't disappearing, their monopoly on outsized returns may be ending. For investors, this creates both risk and opportunity—the key is positioning for what comes next, not what just happened.
Read Next: Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can
Image: Shutterstock
This article The 'Magnificent 7' Are Down 22%—And This $22B Hedge Fund Says These 40 Stocks Are the Real Growth Story originally appeared on Benzinga.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Watch These Novo Nordisk Stock Price Levels After Last Week's 33% Drop
Key Takeaways Novo Nordisk's U.S.-listed shares were slightly higher in recent trading after shedding a third of their value last week, when the company cut its full-year outlook and named a new CEO. The shares had resumed their steep downtrend last week on above-average volume, indicating selling conviction from larger market participants. Investors should watch major support levels on Novo Nordisk's chart around $36 and $29, while also monitoring key overhead areas near $60 and $ Nordisk's (NVO) U.S.-listed shares were up about 2% in recent trading after shedding about a third of their value last week, when the company cut its full-year outlook and named a new CEO, leading Wall Street analysts to downgrade the stock. Since hitting a record high in June last year, Novo Nordisk shares have lost roughly two-thirds of their value, pressured by increasing competition from rival Eli Lilly's (LLY) weight-loss drugs and challenges during trials of the company's next-generation obesity drugs. Below, we take a closer look at Novo Nordisk's weekly chart and use technical analysis to identify major price levels that investors will likely be watching after last week's dramatic sell-off. An Extended Downtrend With last week's drop, Novo Nordisk shares resumed their steep downtrend on above-average trading volume, indicating selling conviction from larger market participants. The sell-off coincided with the relative strength index (RSI) falling to its lowest levels since early May, signaling weakening price momentum, though the indicator neared its oversold threshold, increasing the chances for short-term bounces. It's also worth noting that the 50-week moving average continues to converge toward the 200-week MA, potentially setting the stage for an ominous death cross, a bearish pattern that forecasts lower prices. Let's identify two major support levels on Novo Nordisk's chart worth watching if selling resumes this week and also point out several key overhead areas to monitor during potential recovery efforts. Major Support Levels Worth Watching The first major lower level to watch sits around $36. This area would likely provide support near the upper range of a consolidation period that formed on the chart between October 2020 and April 2021. A more significant move lower could see the shares test lower support at the $29 level. Investors may look for buying opportunities in this area near a horizontal line that connects a range of corresponding price action on the chart between January 2018 and April 2020. Key Overhead Areas to Monitor An initial recovery effort could see the shares climb to overhead resistance around $60. The price may encounter selling pressure in this area near the prominent April trough and April 2022 peak. A more bullish upswing opens the door for a rally toward $78. Investors who have bought Novo Nordisk shares at lower levels may decide to lock in profits in this location near the June peak, which closely aligns with the completion of a pullback in July 2023. The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our warranty and liability disclaimer for more info. As of the date this article was written, the author does not own any of the above securities. Read the original article on Investopedia Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
NCAA Tournament fields to remain at 68 teams in 2026, but future growth is possible
The NCAA men's and women's basketball tournaments will not expand beyond 68 teams in 2026, but future growth remains on the radar. 'Expanding the tournament fields is no longer being contemplated for the 2026 men's and women's basketball championships," Dan Gavitt, NCAA senior vice president of basketball, said in a statement on Monday. "However, the committees will continue conversations on whether to recommend expanding to 72 or 76 teams in advance of the 2027 championships.' NCAA President Charlie Baker has said adding teams could add value to the tournament, and he said the NCAA already has had 'good conversations' with TV partners CBS and Warner Bros., whose deal runs through 2032 at the cost of around $1.1 billion a year. ___ AP college basketball: and
Yahoo
18 minutes ago
- Yahoo
RGTI: Rigetti Shares Jump after Needham hikes target on U.S. quantum momentum
Aug 4 - Rigetti Computing (NASDAQ:RGTI) jumped more than 5% on Monday shortly after Needham raised its price target by $3, signaling fresh momentum in quantum computing. Warning! GuruFocus has detected 3 Warning Signs with RGTI. Analyst Quinn Bolton sees growing buzz around federal programs like DARPA's Quantum Benchmark Initiative (QBI) and the proposed Department of Energy Quantum Leadership Act. He believes those efforts could unlock new research funding and commercial opportunities. Rigetti leads a pack of startups racing to prove quantum machines can outperform classical systems. QBI aims to assess whether quantum devices deliver more value than their cost by 2033. Meanwhile, the DOE bill would allocate $2.5 billion over five years to boost quantum research. Investors weigh the promise of those programs against current realities: most quantum firms still run R&D losses and generate modest revenue. Bolton urges a cautious stance, recommending smaller, speculative positions. Yet his buy rating on Rigetti reflects confidence that government backing could pave the way for breakthroughs and higher stock gains. With Washington pulling out all the stops to keep the U.S. on the leading edge of high-tech, Rigetti advocacy demonstrates the crossroad of policy and private money. This is the place to keep an eye on future legislative actions and DARPA milestones to get new startup catalysts. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
